BNR · Burning Rock Biotech Ltd ADR
United States · RS rating 75 · As of 2026-10-14
| Price | 14.61 USD |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 97 / 96 / 93 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 31 / 24 / 29 |
| Industry group (rank) | Medical-Services (44) |
| EPS growth Q/Q | +6.2% |
| Sales growth Q/Q | -4.0% |
| Distance from 52-week high | +64.4% |
| Market cap (USD) | $221.7M |